Evolving Treatments for Advanced Renal Cell Carcinoma: ASCO 2023 and Beyond - Episode 14
Experts detail their approaches to dosing combination lenvatinib and pembrolizumab for patients with advanced RCC, emphasizing individualized treatment for balanced efficacy and toxicity.